首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年?8期 遗传性肝病的诊断 => 肝脏肿瘤 =>HBV感染者HBsA..
HBV感染者HBsAg、抗-HBs双阳性对肝细胞癌发生影响的Meta分析
Influence of dual positivity of HBsAg and anti-HBs on the development of hepatocellular carcinoma in patients with chronic hepatitis B: A Meta-analysis
文章发布日期:2019年07月05日  来源:  作者:范梦洁,曾争  点击次数:175次  下载次数:15次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的探讨HBV感染者HBsAg、抗-HBs双阳状态对肝细胞癌(HCC)发生的影响。方法检索PubMed、Embase、Cochrane Library英文数据库及中国知网、万方中文数据库1975年7月1日-2019年3月27日发表的有关血清HBsAg、抗-HBs双阳状态对HCC发生风险的文献。采用RevMan5.3和Stata11.2软件对纳入文献数据进行统计分析。对纳入的各研究进行异质性分析,如果各研究间存在显着异质性,则采用随机效应模型分析;若各研究间异质性不显着,则采用固定效应模型分析。比值比(OR)和相应的95%可信区间(95%CI)被用于评估HBsAg、抗-HBs双阳状态与HCC发生的关系。采用Begg漏斗图和Egger检验进行发表偏倚分析。通过每次去除一篇文献的敏感性分析方法评估Meta分析的质量和可信度。结果最终纳入4篇文献,其中2项研究来自韩国人群,2项研究来自中国人群,共3042例患者。Meta分析结果显示,HBsAg、抗-HBs双阳状态与HCC发生之间无显着性关联(OR=1.46,95%CI:0.76~2.80,P=0.25)。基于国别的亚组分析显示,在韩国人群中,双阳状态与HCC发生之间存在显着性关联(OR=2.67,95%CI:1.61~4.43,P=0.000 1);而在中国人群中无显着性关联(OR=0.89,95%CI:0.48~1.64,P=070)。结论HBsAg、抗-HBs双阳状态与HCC发生无明显关联,未来需更多研究证实这一可能。
【Abstract】:ObjectiveTo investigate the influence of dual positivity of HBsAg and anti-HBs on the development of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) infection. MethodsPubMed, Embase, Cochrane Library, CNKI, and Wanfang Data were searched for articles on the influence of dual positivity of HBsAg and anti-HBs on the risk of HCC published from July 1, 1975 to March 27, 2019. RevMan5.3 and Stata11.2 were used for statistical analysis of data. A heterogeneity analysis was performed for the studies included; a random effects model was used in case of significant heterogeneity, and a fixed effects model was used in case of non-significant heterogeneity. Odds ratio (OR) and corresponding 95% confidence interval (CI) were used to investigate the association of dual positivity of HBsAg and anti-HBs with the development of HCC. Begg funnel plots were used to investigate publication bias. By removing one article each time, the sensitivity analysis was used to assess the quality and reliability of the Meta-analysis. ResultsA total of 4 articles were included, with 2 studies in the Korean population and 2 in the Chinese population, and there were 3042 patients in total. The meta-analysis showed that there was no significant association between dual positivity of HBsAg and anti-HBs and the development of HCC (OR=1.46, 95%CI: 0.76-2.80, P=0.25). A country-based subgroup analysis showed significant association between dual positivity of HBsAg and anti-HBs and the development of HCC in the Korean population (OR=2.67, 95%CI: 1.61-4.43, P=0.000 1), while no significant association was found in the Chinese population (OR=0.89, 95%CI: 0.48-1.64, P=0.70). ConclusionThere is no significant association between dual positivity of HBsAg and anti-HBs and the development of HCC, and further studies are needed in future.
【关键字】:乙型肝炎, 慢性; 癌, 肝细胞; 乙型肝炎表面抗原; 乙型肝炎抗体; Meta分析(主题)
【Key words】:hepatitis B, chronic; carcinoma, hepatocellular; hepatitis B surface antigens; hepatitis B antibodies; Meta-analysis as topic
【引证本文】:FAN MJ, ZENG Z. Influence of dual positivity of HBsAg and anti-HBs on the development of hepatocellular carcinoma in patients with chronic hepatitis B: A Meta-analysis[J]. J Clin Hepatol, 2019, 35(8): 1723-1727. (in Chinese)
范梦洁, 曾争. HBV感染者HBsAg、抗-HBs双阳性对肝细胞癌发生影响的Meta分析[J]. 临床肝胆病杂志, 2019, 35(8): 1723-1727.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright ? 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

ag捕鱼王试玩|官网